Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 8—August 2022
CME ACTIVITY - Online Report

Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches

Lisa E. ManhartComments to Author , William M. Geisler, Catriona S. Bradshaw, Jørgen S. Jensen, and David H. Martin
Author affiliations: University of Washington, Seattle, Washington, USA (L.E. Manhart); University of Alabama at Birmingham, Birmingham, Alabama, USA (W.M. Geisler); Monash University and University of Melbourne, Melbourne, Victoria, Australia (C.S. Bradshaw); Statens Serum Institut, Copenhagen, Denmark (J.S. Jensen); Tulane University, New Orleans, Louisiana, USA (D.H. Martin)

Main Article

Figure

Results of systematic search for literature on Mycoplasma genitalium (January 1, 2015–November 30, 2021). STI, sexually transmitted infection.

Figure. Results of systematic search for literature on Mycoplasma genitalium (January 1, 2015–November 30, 2021). STI, sexually transmitted infection.

Main Article

Page created: June 09, 2022
Page updated: July 20, 2022
Page reviewed: July 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external